UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

X-ray Crystal Structure of Human Acidic Fibroblast Growth Factor

Biochemistry (Easton), 1996-02, Vol.35 (7), p.2086-2094

1996

Volltextzugriff (PDF)

Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent (∗)

The Journal of biological chemistry, 1996-01, Vol.271 (2), p.603-606

Thomas, Kenneth A.

1996

Volltextzugriff (PDF)

Tumor‐infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer

International journal of cancer, 2002-05, Vol.99 (3), p.344-351

2002

Volltextzugriff (PDF)

The Seasonal Abundance and Distribution of the Bivalve Lyonsia hyalina (Anomalodesmata: Pandoracea) on a Disturbed New England Mudflat

Northeastern naturalist, 2017-09, Vol.24 (3), p.300-316

2017

Volltextzugriff (PDF)

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

Proceedings of the National Academy of Sciences - PNAS, 1993-11, Vol.90 (22), p.10705-10709

1993

Volltextzugriff (PDF)

Paracrine Expression of a Native Soluble Vascular Endothelial Growth Factor Receptor Inhibits Tumor Growth, Metastasis, and Mortality Rate

Proceedings of the National Academy of Sciences - PNAS, 1998-07, Vol.95 (15), p.8795-8800

1998

Volltextzugriff (PDF)

Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia

American journal of physiology. Heart and circulatory physiology, 1998-03, Vol.274 (3), p.H930-H936

1998

Volltextzugriff (PDF)

Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits

Heart and vessels, 2003-07, Vol.18 (3), p.142-149

2003

Volltextzugriff (PDF)

Synthesis and Initial SAR Studies of 3,6-Disubstituted Pyrazolo[1,5- a]pyrimidines: A New Class of KDR Kinase Inhibitors

Bioorganic & medicinal chemistry letters, 2002-10, Vol.12 (19), p.2767-2770

2002

Volltextzugriff (PDF)

Dynamic Contrast-Enhanced MRI Measurements of Passive Permeability through Blood Retinal Barrier in Diabetic Rats

Investigative ophthalmology & visual science, 2004-07, Vol.45 (7), p.2391-2398

2004

Volltextzugriff (PDF)

Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development

Expert opinion on investigational drugs, 2002-10, Vol.11 (10), p.1447-1465

2002

Volltextzugriff (PDF)

Optimization of a pyrazolo[1,5- a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics

Bioorganic & medicinal chemistry letters, 2002-12, Vol.12 (24), p.3537-3541

2002

Volltextzugriff (PDF)

Vascular Endothelial Growth Factor Receptor KDR Tyrosine Kinase Activity Is Increased by Autophosphorylation of Two Activation Loop Tyrosine Residues

The Journal of biological chemistry, 1999-03, Vol.274 (10), p.6453-6460

1999

Volltextzugriff (PDF)

Purification and Characterization of a Naturally Occurring Vascular Endothelial Growth Factor · Placenta Growth Factor Heterodimer (∗)

The Journal of biological chemistry, 1995-03, Vol.270 (13), p.7717-7723

1995

Volltextzugriff (PDF)

Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinase

Bioorganic & medicinal chemistry letters, 2006-03, Vol.16 (5), p.1146-1150

2006

Volltextzugriff (PDF)

Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG binding

Bioorganic & medicinal chemistry letters, 2004-01, Vol.14 (2), p.351-355

2004

Volltextzugriff (PDF)

Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDR

Bioorganic & medicinal chemistry letters, 2004-02, Vol.14 (4), p.909-912

2004

Volltextzugriff (PDF)

Property-based design of KDR kinase inhibitors

Current medicinal chemistry, 2004-03, Vol.11 (6), p.709-719

2004

Volltextzugriff (PDF)

Globalization and EU Competition Policy

1, 2014

Volltextzugriff (PDF)

The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase

Bioorganic & medicinal chemistry letters, 2004-06, Vol.14 (11), p.2941-2945

2004

Volltextzugriff (PDF)

In his December 25 column of Connecticut Post, William A. Collins once again provided his imaginative overview of the medical liability insurance crisis

Connecticut medicine, 2006-04, Vol.70 (4), p.281

Thomas, Kenneth A

2006

Volltextzugriff (PDF)

2,4-Disubstituted pyrimidines: A novel class of KDR kinase inhibitors

Bioorganic & medicinal chemistry letters, 2003-05, Vol.13 (10), p.1673-1677

2003

Volltextzugriff (PDF)

Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia

Surgery, 1996-08, Vol.120 (2), p.182-188

1996

Volltextzugriff (PDF)

Enhanced hindlimb collateralization induced by acidic fibroblast growth factor is dependent upon femoral artery extraction

Cardiovascular research, 2003-10, Vol.59 (4), p.997-1005

2003

Volltextzugriff (PDF)

1 – 25 von 21.142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16.685)
Mit Volltextzugriff
(16.331)

Publikationsform

9 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(11.084)
Life Sciences & Biomedicine
(8.741)
Humans
(6.430)
Male
(3.794)
Female
(3.731)
Biological And Medical Sciences
(2.945)
Medical Sciences
(2.232)
Middle Aged
(2.220)
Adult
(2.180)
Animals
(2.031)
Physical Sciences
(1.718)
Aged
(1.661)
Technology
(1.071)
Chemistry
(898)
Surgery
(874)
Adolescent
(857)
Cardiovascular System & Cardiology
(845)
Social Sciences
(840)
Fundamental And Applied Biological Sciences. Psychology
(819)
Risk Factors
(733)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(8.290)
EZB Electronic Journals Library
(7.501)
Ingenta
(7.370)
Journals@Ovid Ovid Full Text
(6.288)
NUS Single-Journal Subscriptions
(5.056)
Access via ScienceDirect (Elsevier)
(3.627)
IngentaConnect Journals
(2.597)
Wiley Online Library Journals
(2.410)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(2.175)
JSTOR
(1.748)
Wiley Online Library
(1.638)
Ebook Central Perpetual and DDA
(1.347)
eBooks on EBSCOhost
(1.222)
Nexis Uni
(1.220)
Springer journals
(1.066)
Access via Oxford University Press
(841)
Taylor & Francis
(759)
Taylor & Francis Journals
(705)
Taylor & Francis Online
(664)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(662)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

X-ray Crystal Structure of Human Acidic Fibroblast Growth Factor

Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent (∗)

Tumor‐infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer

The Seasonal Abundance and Distribution of the Bivalve Lyonsia hyalina (Anomalodesmata: Pandoracea) on a Disturbed New England Mudflat

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

Paracrine Expression of a Native Soluble Vascular Endothelial Growth Factor Receptor Inhibits Tumor Growth, Metastasis, and Mortality Rate

Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia

Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits

Synthesis and Initial SAR Studies of 3,6-Disubstituted Pyrazolo[1,5- a]pyrimidines: A New Class of KDR Kinase Inhibitors

Dynamic Contrast-Enhanced MRI Measurements of Passive Permeability through Blood Retinal Barrier in Diabetic Rats

Potent N-(1,3-Thiazol-2-yl)pyridin-2-amine Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors with Excellent Pharmacokinetics and Low Affinity for the hERG Ion Channel

Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development

Optimization of a pyrazolo[1,5- a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics

Vascular Endothelial Growth Factor Receptor KDR Tyrosine Kinase Activity Is Increased by Autophosphorylation of Two Activation Loop Tyrosine Residues

Purification and Characterization of a Naturally Occurring Vascular Endothelial Growth Factor · Placenta Growth Factor Heterodimer (∗)

Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinase

Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG binding

Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDR

Property-based design of KDR kinase inhibitors

Globalization and EU Competition Policy

The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase

In his December 25 column of Connecticut Post, William A. Collins once again provided his imaginative overview of the medical liability insurance crisis

2,4-Disubstituted pyrimidines: A novel class of KDR kinase inhibitors

Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia

Enhanced hindlimb collateralization induced by acidic fibroblast growth factor is dependent upon femoral artery extraction

Suchergebnisse filtern